Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Steroid 17-alpha-hydroxylase (CYP17A1) is a key enzyme in steroid hormone biosynthesis, belonging to the cytochrome P450 superfamily. It exhibits both 17α-hydroxylase and 17,20-lyase activities, essential for the production of glucocorticoids, androgens, and estrogens. Mutations in CYP17A1 can lead to congenital adrenal hyperplasia and other disorders affecting sexual development and electrolyte balance. It is considered a therapeutic target to modulate steroid hormone synthesis.
Inhibition of CYP17A1, blocking the synthesis of cortisol and sex steroids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Steroid 17-alpha-hydroxylase (CYP17A1).